SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer

SIRT5抑制过氧化物酶体ACOX1以防止氧化损伤,并在肝癌中表达下调。

阅读:3
作者:Xiu-Fei Chen ,Meng-Xin Tian ,Ren-Qiang Sun ,Meng-Li Zhang ,Li-Sha Zhou ,Lei Jin ,Lei-Lei Chen ,Wen-Jie Zhou ,Kun-Long Duan ,Yu-Jia Chen ,Chao Gao ,Zhou-Li Cheng ,Fang Wang ,Jin-Ye Zhang ,Yi-Ping Sun ,Hong-Xiu Yu ,Yu-Zheng Zhao ,Yi Yang ,Wei-Ren Liu ,Ying-Hong Shi ,Yue Xiong ,Kun-Liang Guan ,Dan Ye

Abstract

Peroxisomes account for ~35% of total H2O2 generation in mammalian tissues. Peroxisomal ACOX1 (acyl-CoA oxidase 1) is the first and rate-limiting enzyme in fatty acid β-oxidation and a major producer of H2O2 ACOX1 dysfunction is linked to peroxisomal disorders and hepatocarcinogenesis. Here, we show that the deacetylase sirtuin 5 (SIRT5) is present in peroxisomes and that ACOX1 is a physiological substrate of SIRT5. Mechanistically, SIRT5-mediated desuccinylation inhibits ACOX1 activity by suppressing its active dimer formation in both cultured cells and mouse livers. Deletion of SIRT5 increases H2O2 production and oxidative DNA damage, which can be alleviated by ACOX1 knockdown. We show that SIRT5 downregulation is associated with increased succinylation and activity of ACOX1 and oxidative DNA damage response in hepatocellular carcinoma (HCC). Our study reveals a novel role of SIRT5 in inhibiting peroxisome-induced oxidative stress, in liver protection, and in suppressing HCC development. Keywords: ACOX1; SIRT5; liver cancer; oxidative stress; succinylation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。